Cyclo Therapeutics, Inc.·4

Nov 30, 9:05 AM ET

Toig Randall M. 4

4 · Cyclo Therapeutics, Inc. · Filed Nov 30, 2023

Insider Transaction Report

Form 4
Period: 2023-11-28
Transactions
  • Award

    Common Stock

    2023-11-28+8,86297,375 total
Footnotes (1)
  • [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34 per share of common stock on November 28, 2023.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4